Allianz Asset Management GmbH - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$5,364,000
+130.5%
45,300
+129.9%
0.01%
+150.0%
Q4 2020$2,327,000
+29.6%
19,700
+9.0%
0.00%0.0%
Q2 2018$1,795,000
+22.7%
18,0660.0%0.00%
+100.0%
Q1 2018$1,463,000
+2.8%
18,0660.0%0.00%0.0%
Q4 2017$1,423,000
-22.4%
18,066
-9.1%
0.00%
-50.0%
Q3 2017$1,834,00019,8720.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2021
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders